<?xml version="1.0" encoding="UTF-8"?>
<p>The drug formulation and bioavailability of TQ is restricted by its hydrophobic characteristics [
 <xref rid="B59-antioxidants-09-01260" ref-type="bibr">59</xref>]. Administration of TQ can occur through several routes, including systemic intraperitoneal, intravenous, oral subacute and sub-chronic administration, besides the localized drug delivery of TQ [
 <xref rid="B6-antioxidants-09-01260" ref-type="bibr">6</xref>,
 <xref rid="B60-antioxidants-09-01260" ref-type="bibr">60</xref>,
 <xref rid="B61-antioxidants-09-01260" ref-type="bibr">61</xref>]. In the current investigation the reviewed in vivo studies reported the local periodontal application of 0.1–0.2% TQ gel [
 <xref rid="B62-antioxidants-09-01260" ref-type="bibr">62</xref>,
 <xref rid="B63-antioxidants-09-01260" ref-type="bibr">63</xref>,
 <xref rid="B64-antioxidants-09-01260" ref-type="bibr">64</xref>] and similarly in the form of fabricated periodontal chips containing 2.5 mg of TQ [
 <xref rid="B65-antioxidants-09-01260" ref-type="bibr">65</xref>]. One animal investigation reported systemic TQ administration by gastric feeding, at a rate of 10 mg/kg/d [
 <xref rid="B66-antioxidants-09-01260" ref-type="bibr">66</xref>]. In vitro studies on TQ or 
 <italic>NS</italic> extract effects on periodontal diseases and bacteria administered solutions of 2% 
 <italic>NS</italic> extract [
 <xref rid="B63-antioxidants-09-01260" ref-type="bibr">63</xref>] and 0.01–10% concentrations of TQ [
 <xref rid="B67-antioxidants-09-01260" ref-type="bibr">67</xref>,
 <xref rid="B68-antioxidants-09-01260" ref-type="bibr">68</xref>]. All tested concentrations and routes of drug delivery showed significant periodontal health-favoring outcomes in terms of clinical periodontal parameters as plaque index (PI), gingival index (GI), probing pocket depth (PPD), bleeding on probing (BOP), clinical attachment levels (CAL) [
 <xref rid="B62-antioxidants-09-01260" ref-type="bibr">62</xref>,
 <xref rid="B65-antioxidants-09-01260" ref-type="bibr">65</xref>,
 <xref rid="B66-antioxidants-09-01260" ref-type="bibr">66</xref>], as well as molecular parameters as gingival crevicular fluid alkaline phosphatase levels (GCF-ALP) [
 <xref rid="B66-antioxidants-09-01260" ref-type="bibr">66</xref>] and cytokine/chemokine levels [
 <xref rid="B63-antioxidants-09-01260" ref-type="bibr">63</xref>]. Microbiological and histological parameters similarly showed significant improvements as observed in biofilm formation and inflammatory cell infiltration (ICI) [
 <xref rid="B66-antioxidants-09-01260" ref-type="bibr">66</xref>,
 <xref rid="B67-antioxidants-09-01260" ref-type="bibr">67</xref>,
 <xref rid="B68-antioxidants-09-01260" ref-type="bibr">68</xref>,
 <xref rid="B69-antioxidants-09-01260" ref-type="bibr">69</xref>]. 
</p>
